Vexicitinib

Overview

Vexicitinib (Vexicitinibum) is a SYK and JAK2 inhibitor with IC 50 values both less than 10 nM. Vexicitinib exhibits anti-inflammatory and immunosuppressive effects . Vexicitinib can be used in tumor-related research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Syk | Products > Signaling Pathways > JAK

Product Information

• Catalog No.: HY-184063
• CAS No.: 2230362-69-1
• Molecular Formula: C22H27N7O4S
• Molecular Weight: 485.56
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source